Tranquil Healthcare Fund Launches $50 Million Regulation A Offering

The offering, structured as a Tier 2 Regulation A investment, sets a purchase price of $10 per share with a minimum entry threshold of $2,500. Investors committing at least $100,000 are eligible for a 10% bonus in additional shares. The company intends to deploy the net proceeds primarily as secured and unsecured loans to clinic operators, specifically to cover the procurement or leasing of specialized TMS equipment.

Tyler Ehler, CEO of Tranquil Healthcare Holdings, which manages the fund, stated that the initiative is designed to support experienced operators while increasing patient access to evidence-based neuromodulation treatments. TMS therapy, cleared by the FDA in 2008 for major depressive disorder, utilizes targeted magnetic pulses to stimulate brain regions linked to mood regulation. Interested parties are directed to the company's official offering circular for full disclosure regarding risks and investment limitations.